Naurex

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Naurex Inc.
Website www.naurex.com

Naurex Inc. is a pharmaceutical company which is developing the drug candidates rapastinel (GLYX-13) and NRX-1074, NMDA receptor modulators, as novel, next-generation antidepressants.[1][2][3]

On July 26, 2015, it was announced that Allergan would be acquiring Naurex for $560 million.[4]

See also

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This corporation or company article is a stub. You can help Wikipedia by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  4. ↑ Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=Naurex&oldid=699814617"